Lefu Huang

Expression of Lymphocyte-Activation Gene 3 (LAG-3) Immune Checkpoint Receptor Identifies a Tumor-Reactive T Cell Population in the Peripheral Blood of Patients with Colorectal Cancer

Jun Ren, G. Qiao, Jiangping Wu, 2019, Medical science monitor : international medical journal of experimental and clinical research.

Restored CD8+PD-1+ T Cells Facilitate the Response to Anti-PD-1 for Patients With Pancreatic Ductal Adenocarcinoma

Jing Zhao, Yufeng Yuan, G. Qiao, 2021, Frontiers in Oncology.

Methylation silencing CDH23 is a poor prognostic marker in diffuse large B-cell lymphoma

Bin Wang, Weijing Zhang, Baoping Cao, 2021, Aging.

Safety and Efficacy of Humanized Versus Murinized CD19 and CD22 CAR T-Cell Cocktail Therapy for Refractory/Relapsed B-Cell Lymphoma

Wen-qian Li, P. Lu, Xian Zhang, 2022, Cells.

Predictive significance of T cell subset changes during ex vivo generation of adoptive cellular therapy products for the treatment of advanced non-small cell lung cancer

H. Lyerly, M. Morse, Jun Ren, 2019, Oncology letters.

Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective Study

X. Yi, Yanjie Zhao, H. Lyerly, 2017, Clinical Cancer Research.

Expansion of CD3+CD8+PD1+ T lymphocytes and TCR repertoire diversity predict clinical responses to adoptive cell therapy in advanced gastric cancer.

G. Qiao, Qian Zhu, Yuze Zhao, 2022, American journal of cancer research.

Retracted: Expression of Lymphocyte-Activation Gene 3 (LAG-3) Immune Checkpoint Receptor Identifies a Tumor-Reactive T Cell Population in the Peripheral Blood of Patients with Colorectal Cancer

Jun Ren, G. Qiao, Lefu Huang, 2019, Medical science monitor : international medical journal of experimental and clinical research.